TRAF6 and neoplasm: Similarly, the TRAF6 inhibitor decreases the population of intratumor Tregs by impeding the migration of Tregs towards the tumor, thus enhancing T cell-mediated antitumor immunity and thereby inhibiting the growth of Hepa1-6 tumor in immunocompetent mice, but not in immunodeficient mice [135].